These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1426026)

  • 1. Differential effects of cytochrome P-450 induction on ligand binding to sigma receptors.
    Basile AS; Paul IA; de Costa B
    Eur J Pharmacol; 1992 Sep; 227(1):95-8. PubMed ID: 1426026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H](+)-pentazocine binding to rat brain sigma 1 receptors.
    Cagnotto A; Bastone A; Mennini T
    Eur J Pharmacol; 1994 Jan; 266(2):131-8. PubMed ID: 8157067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. sigma recognition sites in brain and peripheral tissues. Characterization and effects of cytochrome P450 inhibitors.
    DeHaven-Hudkins DL; Lanyon LF; Ford-Rice FY; Ator MA
    Biochem Pharmacol; 1994 Mar; 47(7):1231-9. PubMed ID: 8161352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytochromes P-450 are not involved in the modulation of the N-methyl-D-aspartate response by sigma ligands in the rat CA3 dorsal hippocampus.
    Monnet FP; Debonnel G; de Montigny C
    Synapse; 1993 Jan; 13(1):30-8. PubMed ID: 8427011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NE-100, a novel potent sigma ligand, preferentially binds to sigma 1 binding sites in guinea pig brain.
    Chaki S; Tanaka M; Muramatsu M; Otomo S
    Eur J Pharmacol; 1994 Jan; 251(1):R1-2. PubMed ID: 8137864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated haloperidol treatment decreases sigma(1) receptor binding but does not affect its mRNA levels in the guinea pig or rat brain.
    Inoue A; Sugita S; Shoji H; Ichimoto H; Hide I; Nakata Y
    Eur J Pharmacol; 2000 Aug; 401(3):307-16. PubMed ID: 10936488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]1,3-di(2-tolyl)guanidine and [3H](+)pentazocine binding sites in the rat brain: autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes.
    Bouchard P; Quirion R
    Neuroscience; 1997 Jan; 76(2):467-77. PubMed ID: 9015331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
    Monnet FP; de Costa BR; Bowen WD
    Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
    Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD
    Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,3-Di(2-[5-3H]tolyl)guanidine labels more than one site in rat forebrain.
    Codd EE; Shank RP
    Eur J Pharmacol; 1992 Jul; 217(2-3):149-52. PubMed ID: 1425936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepancies in characterization of sigma sites in the mouse central nervous system.
    Kovács KJ; Larson AA
    Eur J Pharmacol; 1995 Oct; 285(2):127-34. PubMed ID: 8566130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous binding of sigma radioligands in the rat brain and liver: possible relationship to subforms of cytochrome P-450.
    Ross SB
    Pharmacol Toxicol; 1991 Apr; 68(4):293-301. PubMed ID: 1650944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of 1,3-di(2-[5-3H]tolyl) guanidine with sigma 2 binding sites in rat heart membrane preparations.
    Dumont M; Lemaire S
    Eur J Pharmacol; 1991 Dec; 209(3):245-8. PubMed ID: 1665796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ionic zinc may function as an endogenous ligand for the haloperidol-sensitive sigma 2 receptor in rat brain.
    Connor MA; Chavkin C
    Mol Pharmacol; 1992 Sep; 42(3):471-9. PubMed ID: 1406599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoradiographic distribution of [3H](+)-pentazocine and [3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative study.
    Walker JM; Bowen WD; Goldstein SR; Roberts AH; Patrick SL; Hohmann AG; DeCosta B
    Brain Res; 1992 May; 581(1):33-8. PubMed ID: 1323368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]1,3-di(2-tolyl) guanidine binds to a sigma 2 receptor on Jurkat cell membranes, but sigma compounds fail to influence immunomodulatory events in human peripheral blood lymphocytes.
    DeHaven-Hudkins DL; Daubert JD; Sawutz DG; Tiberio L; Baine Y
    Immunopharmacology; 1996 Oct; 35(1):27-39. PubMed ID: 8913792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple [3H]DTG binding sites in guinea pig cerebellum: evidence for the presence of non-specific binding.
    Basile AS; DeCosta B; Paul IA
    Eur J Pharmacol; 1994 Feb; 252(2):139-46. PubMed ID: 8157054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of specific binding sites for [3H]-1,3-di-o-tolyl-guanidine (DTG) in the rat glioma cell line C6-BU-1.
    Georg A; Friedl A
    Glia; 1992; 6(4):258-63. PubMed ID: 1464457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between modulation of the cerebellorubrospinal system in the in vitro turtle brain and changes in motor behavior in rats: effects of novel sigma ligands.
    Matsumoto RR; Bowen WD; de Costa BR; Houk JC
    Brain Res Bull; 1999 Mar; 48(5):497-508. PubMed ID: 10372510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential solubilization of rat liver sigma 1 and sigma 2 receptors: retention of sigma 2 sites in particulate fractions.
    Torrence-Campbell C; Bowen WD
    Eur J Pharmacol; 1996 May; 304(1-3):201-10. PubMed ID: 8813603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.